For citations:
Kolbin A.S., Kasimova A.R. Clinical and economic assessment of using IRS®19 for the treatment and prevention of acute respiratory infections in children. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2024;17(2):182-190. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2024.244
Views PDF (Rus): 128
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 